Connection

Phillip Buckhaults to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Phillip Buckhaults has written about Xenograft Model Antitumor Assays.
Phillip Buckhaults
Connection Strength
0.106
Xenograft Model Antitumor Assays
  1. PRDM16 suppresses HIF-targeted gene expression in kidney cancer. J Exp Med. 2020 06 01; 217(6).
    View in: PubMed
    Score: 0.040
  2. Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal Cancer. Clin Cancer Res. 2018 12 15; 24(24):6433-6446.
    View in: PubMed
    Score: 0.035
  3. O-Linked N-Acetylglucosamine (O-GlcNAc) Expression Levels Epigenetically Regulate Colon Cancer Tumorigenesis by Affecting the Cancer Stem Cell Compartment via Modulating Expression of Transcriptional Factor MYBL1. J Biol Chem. 2017 03 10; 292(10):4123-4137.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.